vs

Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.

IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $153.1M, roughly 1.4× CPI Card Group Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 4.8%, a 52.6% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $35.2M).

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.

CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.

IDYA vs PMTS — Head-to-Head

Bigger by revenue
IDYA
IDYA
1.4× larger
IDYA
$207.8M
$153.1M
PMTS
Higher net margin
IDYA
IDYA
52.6% more per $
IDYA
57.4%
4.8%
PMTS
More free cash flow
IDYA
IDYA
$107.0M more FCF
IDYA
$142.2M
$35.2M
PMTS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
IDYA
IDYA
PMTS
PMTS
Revenue
$207.8M
$153.1M
Net Profit
$119.2M
$7.3M
Gross Margin
31.5%
Operating Margin
52.2%
12.0%
Net Margin
57.4%
4.8%
Revenue YoY
22.3%
Net Profit YoY
330.1%
8.5%
EPS (diluted)
$1.33
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDYA
IDYA
PMTS
PMTS
Q4 25
$153.1M
Q3 25
$207.8M
$138.0M
Q2 25
$129.8M
Q1 25
$122.8M
Q4 24
$125.1M
Q3 24
$0
$124.8M
Q2 24
$0
$118.8M
Q1 24
$0
$111.9M
Net Profit
IDYA
IDYA
PMTS
PMTS
Q4 25
$7.3M
Q3 25
$119.2M
$2.3M
Q2 25
$518.0K
Q1 25
$4.8M
Q4 24
$6.8M
Q3 24
$-51.8M
$1.3M
Q2 24
$-52.8M
$6.0M
Q1 24
$-39.6M
$5.5M
Gross Margin
IDYA
IDYA
PMTS
PMTS
Q4 25
31.5%
Q3 25
29.7%
Q2 25
30.9%
Q1 25
33.2%
Q4 24
34.1%
Q3 24
35.8%
Q2 24
35.7%
Q1 24
37.1%
Operating Margin
IDYA
IDYA
PMTS
PMTS
Q4 25
12.0%
Q3 25
52.2%
9.4%
Q2 25
7.3%
Q1 25
11.5%
Q4 24
12.7%
Q3 24
14.3%
Q2 24
12.5%
Q1 24
12.6%
Net Margin
IDYA
IDYA
PMTS
PMTS
Q4 25
4.8%
Q3 25
57.4%
1.7%
Q2 25
0.4%
Q1 25
3.9%
Q4 24
5.4%
Q3 24
1.0%
Q2 24
5.1%
Q1 24
4.9%
EPS (diluted)
IDYA
IDYA
PMTS
PMTS
Q4 25
$0.62
Q3 25
$1.33
$0.19
Q2 25
$0.04
Q1 25
$0.40
Q4 24
$0.56
Q3 24
$-0.60
$0.11
Q2 24
$-0.68
$0.51
Q1 24
$-0.53
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDYA
IDYA
PMTS
PMTS
Cash + ST InvestmentsLiquidity on hand
$786.9M
$21.7M
Total DebtLower is stronger
$286.7M
Stockholders' EquityBook value
$1.1B
$-17.3M
Total Assets
$1.2B
$403.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDYA
IDYA
PMTS
PMTS
Q4 25
$21.7M
Q3 25
$786.9M
$16.0M
Q2 25
$17.1M
Q1 25
$31.5M
Q4 24
$33.5M
Q3 24
$920.0M
$14.7M
Q2 24
$701.7M
$7.5M
Q1 24
$698.8M
$17.1M
Total Debt
IDYA
IDYA
PMTS
PMTS
Q4 25
$286.7M
Q3 25
$308.4M
Q2 25
$310.9M
Q1 25
$280.7M
Q4 24
$280.4M
Q3 24
$280.2M
Q2 24
$269.7M
Q1 24
$265.3M
Stockholders' Equity
IDYA
IDYA
PMTS
PMTS
Q4 25
$-17.3M
Q3 25
$1.1B
$-25.7M
Q2 25
$-29.0M
Q1 25
$-29.7M
Q4 24
$-35.6M
Q3 24
$1.2B
$-42.8M
Q2 24
$931.7M
$-44.6M
Q1 24
$935.3M
$-48.5M
Total Assets
IDYA
IDYA
PMTS
PMTS
Q4 25
$403.2M
Q3 25
$1.2B
$407.1M
Q2 25
$399.8M
Q1 25
$351.9M
Q4 24
$349.7M
Q3 24
$1.2B
$342.3M
Q2 24
$973.7M
$321.4M
Q1 24
$961.5M
$319.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDYA
IDYA
PMTS
PMTS
Operating Cash FlowLast quarter
$142.2M
$39.6M
Free Cash FlowOCF − Capex
$142.2M
$35.2M
FCF MarginFCF / Revenue
68.4%
23.0%
Capex IntensityCapex / Revenue
0.0%
2.9%
Cash ConversionOCF / Net Profit
1.19×
5.39×
TTM Free Cash FlowTrailing 4 quarters
$13.5M
$41.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDYA
IDYA
PMTS
PMTS
Q4 25
$39.6M
Q3 25
$142.2M
$10.0M
Q2 25
$4.3M
Q1 25
$5.6M
Q4 24
$26.7M
Q3 24
$-49.2M
$12.5M
Q2 24
$-32.9M
$-4.8M
Q1 24
$-43.8M
$8.9M
Free Cash Flow
IDYA
IDYA
PMTS
PMTS
Q4 25
$35.2M
Q3 25
$142.2M
$5.3M
Q2 25
$533.0K
Q1 25
$292.0K
Q4 24
$21.6M
Q3 24
$-49.7M
$11.1M
Q2 24
$-33.9M
$-6.0M
Q1 24
$-45.1M
$7.4M
FCF Margin
IDYA
IDYA
PMTS
PMTS
Q4 25
23.0%
Q3 25
68.4%
3.8%
Q2 25
0.4%
Q1 25
0.2%
Q4 24
17.3%
Q3 24
8.9%
Q2 24
-5.0%
Q1 24
6.6%
Capex Intensity
IDYA
IDYA
PMTS
PMTS
Q4 25
2.9%
Q3 25
0.0%
3.4%
Q2 25
2.9%
Q1 25
4.3%
Q4 24
4.0%
Q3 24
1.2%
Q2 24
1.0%
Q1 24
1.3%
Cash Conversion
IDYA
IDYA
PMTS
PMTS
Q4 25
5.39×
Q3 25
1.19×
4.32×
Q2 25
8.39×
Q1 25
1.17×
Q4 24
3.94×
Q3 24
9.70×
Q2 24
-0.79×
Q1 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDYA
IDYA

Segment breakdown not available.

PMTS
PMTS

US Debit And Credit$128.9M84%
US Prepaid Debit$24.4M16%

Related Comparisons